rapid daratumumab infusion for mm
Published 4 years ago • 149 plays • Length 2:18Download video MP4
Download video MP3
Similar videos
-
2:43
impact of the addition of daratumumab to the frontline treatment of patients with al amyloidosis
-
2:08
novel drug delivery method to prevent daratumumab infusion-related reactions in mm
-
1:30
rapid infusion treatment of mm
-
1:04
revolutionizing mm treatment with daratumumab
-
1:09
daratumumab enhancement for mm: the clinical impact
-
2:39
subcutaneous daratumumab: an update on the latest mm clinical trials
-
1:21
daratumumab with atra in r/r mm
-
2:42
promising results for daratumumab in the front line setting
-
13:43
darzalex® iv (daratumumab) mechanism of action for multiple myeloma
-
1:00:47
using daratumumab to treat high-risk myeloma patients
-
2:02
iberdomide with cyclophosphamide and dexamethasone in rrmm: first results from the icon study
-
3:15
addition of daratumumab to r/r myeloma regimens improves outcomes
-
1:40
can daratumumab be used to treat refractory mm?
-
2:49
trimm-2 update: talquetamab daratumumab in r/r multiple myeloma
-
1:44
trimm-2: talquetamab daratumumab in patients with r/r multiple myeloma
-
4:22
optimizing treatment sequencing in multiple myeloma: daratumumab upfront versus subsequent lines
-
2:09
the candor trial extended follow-up: daratumumab for r/r myeloma
-
1:35
rationale for using immunotherapies in the frontline treatment of multiple myeloma
-
0:52
the future of daratumumab in multiple myeloma
-
0:52
phase i study of ft538, an ipsc-derived nk cell therapy, with daratumumab in r/r multiple myeloma
-
2:09
dart4mm: daratumumab in myeloma patients with vgpr to first-line therapy
-
1:06
d-kd for rrmm: mmy1001 final analysis